| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Journal of Advanced Research LetPub Score 8.0
59 ratings
Rate
Reputation 8.3 Influence 7.5 Speed 8.3 | ||||||||||||||||
| 期刊簡稱 | J ADV RES | ||||||||||||||||
| ISSN | 2090-1232 | ||||||||||||||||
| E-ISSN | 2090-1224 | ||||||||||||||||
| h-index | 36 | ||||||||||||||||
| CiteScore |
| ||||||||||||||||
| 自引率 (2023-2024) | 0.90%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | https://www.journals.elsevier.com/journal-of-advanced-research | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/JARE | ||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||
| 出版商 | Cairo University | ||||||||||||||||
| 主題領域 | Multidisciplinary | ||||||||||||||||
| 出版國/地區 | Egypt | ||||||||||||||||
| 發行頻率 | |||||||||||||||||
| 創刊年 | 0 | ||||||||||||||||
| 每年文章數 | 546每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 100.00% | ||||||||||||||||
OA Related Info![]() | APC: Yes( USD4400; ) APC waiver:Check Notes Other charges: No Keywords: science、medicine、dentistry、agriculture、engineering、information technology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | ||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2090-1232%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 12 Weeks | ||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
| [Journal of Advanced Research] 的評論 | 撰寫評論 |
| 作者: 无xiao 領域: 综合性期刊 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-07-23 11:22:03 評論於 I am also about four days away. |
| 作者: 我我我我我1234 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-07-23 10:20:18 評論於 How long does the technical review usually take? It has been more than twenty days since I submitted my application, and it is still under technical review. |
| 作者: 下一篇中10分 領域: 综合性期刊 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-07-01 14:10:58 評論於 Over 30,000 |
| 作者: 长根的植物 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-26 15:49:40 評論於 Is this journal worth submitting to? I really want to have an article on integrative omics. |
| 作者: 史迪奇gogo 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-06-25 17:02:31 評論於 The quality of the submissions is required to be high, with strict requirements for innovation and clear exploration of pharmacological mechanisms. The number of submissions may suddenly increase, leading to a slower overall review speed. It is hoped that the journal will adhere to its original intention, prioritize quality over quantity, and improve with each issue. |
| 作者: Lingerzh 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-25 09:26:51 評論於 Are all the articles open access (OA)? How much is the page charge? Thank you. |
| 作者: Lingerzh 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-25 09:25:42 評論於 May I ask how much is the layout fee? Thank you. |
| 作者: 海绵宝宝不吸水 領域: 工程技术 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-22 17:17:57 評論於 It's too slow. I submitted on April 9th, and it is still "With Editor" until now. |
| 作者: 下一篇中10分 領域: 综合性期刊 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-06-20 17:21:13 評論於 Indeed, if the self-citation rate of this journal were higher, the impact factor would exceed 20. |
| 作者: 读博/投文章好难啊 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-20 16:08:43 評論於 With a self-citation rate of less than 2%, how could it be put on hold, even though it didn't win, it was rejected... |
| 作者: 下一篇中10分 領域: 综合性期刊 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-06-20 15:17:43 評論於 Absolutely impossible to put on hold. Stop criticizing, wait until the investment is successful, the journal just lacks support. |
| 作者: HappyChen 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-06-17 17:41:25 評論於 On hold directly next year. |
| 作者: 下一篇中10分 領域: 综合性期刊 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-06-17 14:10:27 評論於 Great, the impact factor has reached 17 points, and there is hope to exceed 20 next year. |
| 作者: 大炮 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-05-03 03:01:00 評論於 The following articles were indeed not submitted. It's up to each individual's choice. If you think it's good, submit it; if you're not happy with it, then don't submit it. |
| 作者: 大炮 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-05-03 02:57:36 評論於 Just making a few complaints, and you come at me aggressively, is that interesting? This platform is meant for everyone to express their opinions. That article ended up in a well-established magazine with a similar score. The professional recognition there is much higher. Public platforms are not suitable for posting articles. |
| 作者: Toryn 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-29 22:05:19 評論於 It feels like JAR is almost on hold, just like IJS. Everyone should be cautious about investing. The same goes for CD... |
| 作者: oppo 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-25 10:59:47 評論於 This journal has a long submission process in pharmacology and medicine. It took me 8 months from submission to acceptance, during which the reviewers requested WB3 repeated experiments. The reviewers' questions were very professional, and it took me an additional 3-4 months to conduct the supplementary experiments. You were lucky to be accepted directly in 3 months, but not everyone is as lucky as you when submitting to this journal. Most people still need to conduct real supplementary experiments and provide original data. Please respect the efforts of these people. Thank you! |
| 作者: oppo 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-25 10:57:39 評論於 This journal has a very long submission process in the field of pharmacology and medicine. It took me 8 months from submission to acceptance, during which the reviewers requested three repetitions of western blot, and the reviewer's questions were very professional. It took 3-4 months to complete the additional experiments. You were lucky to be accepted directly in 3 months, but not everyone is as lucky as you when submitting to this journal. Most people still have to conduct additional experiments and provide original data. Please respect the hard work of these individuals. Thank you. |
| 作者: oppo 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-25 10:53:11 評論於 This journal requires three rounds of revisions from the authors, without any rejections. The technical review process is quite lengthy, and manuscripts that are submitted quickly are less likely to be sent for review. The longer the review process, the more likely the manuscript will be accepted. |
| 作者: XuJie 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-23 04:00:44 評論於 Which school can we communicate with if they share the same IP address in Chongqing? |
| 作者: geoffreychow 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-04-21 13:53:29 評論於 10.28 Submission 12.11 Notification for additional materials, provide three original uncropped Western blots (the same band should have three repeated uncropped original images) 01.13 Submission of materials 01.18 Assignment of manuscript number, sent for external review 2.13 Notification for major revision, deadline by 3.18 3.8 Major revision returned, with editor 4.10 Revised manuscript under review, should be sent for external review. The time spent at each stage in the editor's hands is indeed quite long 4.13 Informed that external review of revised manuscript is complete 4.19 Decision in progress 4.20 Acceptance |
| 作者: geoffreychow 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-12 17:51:37 評論於 10.28 Submission 12.11 Notification for additional materials, provide three original Western blots that have not been cropped three times (the same strip should have three repetitions of the original uncropped Western blot) 01.13 Submission of materials 01.18 Assignment of manuscript number, sent for external review 2.13 Notification for major revisions, deadline is 3.18 3.8 Major revisions returned, with editor 4.10 Revised manuscript under review, should be sent for external review. The time spent in the hands of the editor at each stage is indeed very long. |
| 作者: 何博文 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-07 14:46:46 評論於 Have any brothers received this resubmission for revision? Does it need to be changed or can it be submitted directly? "When you are ready to resubmit, please log in as an author at https://www.editorialmanager.com/JARE/ and navigate to the "Author's Resubmissions" folder. There, you can edit your submission by clicking on "Edit Submission" under the "Action Links" menu. Thank you for considering our journal, and we look forward to receiving your submission. Sincerely, Journal of Advanced Research Technical Comments (if applicable): Structured Abstract: - Original papers must include a structured abstract of no more than 300 words, arranged under the following headings: Introduction: Describe the mechanism, history, and/or relationship of the topic to a particular issue. Objective: State the research objective. What is this study trying to prove? Methods: Briefly describe the experimental design. Results: Report the research findings. Conclusion: Analyze the research results and relate them to the research objective." |
| 作者: oppo 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-03-29 14:03:30 評論於 Any journal will have uneven levels, as, nc is also said to be water, which cannot be avoided, but this journal still has good articles. I checked the data of JAR: 212 articles in 2024 and 372 articles in 2025 (doubled), but the IF in 2025 is 13.0, and the timely IF in March 2026 has reached 15. Self-citation rate is 0.7%, acceptance rate is 5-6%. The data is clear: the number of articles has increased by 75%, and the IF is also increasing, not relying on self-citation. Obviously, the basic plate is the same as last year, so why are the categories different? [Handshake][Handshake], what we are talking about now is the algorithm of the new area, if they say they are using the previous surpassing index, then why did the categories change? Moreover, not only JAR, why have other top journals in different fields become 2nd or even 3rd tier? Why has MDPI been upgraded to the 2nd tier? What is this algorithm, I hope it can be transparent and clear. |
| 作者: oppo 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-03-29 14:02:01 評論於 Any journal will have uneven levels, as, NC is also said to be water, this cannot be avoided, but this journal still has some good articles. I checked the data of JAR: 212 articles in 2024, 372 articles in 2025 (doubled) But the IF in 2025 is 13.0, and the IF in March 2026 has reached 15. Self-citation rate is 0.7%, acceptance rate is 5-6%. The data is very clear: the number of articles has increased by 75%, and the IF is also increasing, not relying on self-citation. Obviously, the basic plate is the same as last year, so why are the subcategories different? [Shake hands] [Shake hands], what we are talking about now is the algorithm of the new subcategories. If they say they are using the previous surpass index, then why have the subcategories changed? And not only JAR, why have other top journals in different fields become 2nd or even 3rd category, why has MDPI been upgraded to 2nd category, what is this algorithm, hoping for transparency, explain clearly. |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
Contact us